Let’s Look at LinkedIn
LinkedIn (LNKD) is always too-high-to-buy, but perhaps the stock will fall after it reports earnings Feb 5th.
LinkedIn (LNKD) is always too-high-to-buy, but perhaps the stock will fall after it reports earnings Feb 5th.
Chinese Internet stocks & Biotech stocks will lead the stock market in 2015.
Chinese wealth manager Noah Holdings (NOAH) is still under the radar even though NOAH is growing 50%.
Qihoo (QIHU) is growing like mad yet the stock is half what it was, and sells for just 15x EPS. Why?
CaesarStone (CSTE) is building a quartz empire, and we are going along for the ride.
Things couldn’t be worse for Nu Skin (NUS) which is why I feel the stock has bottomed.
BitAuto.com (BITA) is becoming more diversified as it grows from ads into online sales, financing and used cars.
Shares of Vipshop (VIPS) aren’t so perfect anymore, but VIPS still has huge upside.
Biogen’s (BIIB) new Alzheimer’s drug could be a blockbuster, so I will add it to the Growth Portfolio & Aggressive Growth Portfolio today.
With 50% profit growth on the horizon and a P/E of only 16, YY (YY) is my top pick for 2015.
MasterCard (MA) has lots of momentum right now, but I don’t see the stock doing much in 2015.